BIOFUNCTIONALIZATION WITH RGD PEPTIDES AND VASCULAR ENDOTHELIAL GROWTH FACTOR ENHANCES ENDOTHELIALIZATION OF BIODEGRADABLE SMALL-DIAMETER VASCULAR GRAFTS
https://doi.org/10.29001/2073-8552-2017-32-1-96-101
Abstract
Tissueengineered vascular grafts are the perfect candidates as vascular conduits for cardiovascular bypass or arterial replacement surgery. Aim: To compare efficiency of the grafts blended of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with poly(е-caprolactone) and optionally modified with either vascular endothelial growth factor (VEGF) or RGD peptides. Materials and Methods. Electrospun, 2 mm diameter grafts optionally modified with either VEGF or RGD peptides were implanted into rat abdominal aorta (n=20 per each group). In 1, 3, 6, 9, or 12 months, onefifth of rats in each group were sacrificed (n=4 per each time point) for the following histological and immunofluorescence examination of the explanted grafts. Results. At 12 months postimplantation, modification with either VEGF or RGD peptides induced formation of endothelial cell monolayer and a basement membrane-like structure in three-fourths of the grafts, which was three-fold higher compared to unmodified grafts. Furthermore, we detected CD34-positive cells, i.e. endothelial progenitor cells, as early as 1 month postimplantation in both VEGF- and RGD-treated grafts.
About the Authors
E. O. KrivkinaRussian Federation
L. V. Antonova
Russian Federation
V. V. Sevostyanova
Russian Federation
E. A. Velikanova
Russian Federation
A. V. Mironov
Russian Federation
References
1. Ren X., Feng Y., Guo J. et al. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications // Chem. Soc. Rev. – 2015. – Vol. 44, No. 15. – P. 5680–5742.
2. Wang F., Li Y., Shen Y. et al. The functions and applications of RGD in tumor therapy and tissue engineering // Int. J. Mol. Sci. – 2013. – Vol. 14, No. 9. – P. 13447–13462.
3. Harburger D.S., Calderwood D.A. Integrin signalling at a glance // J. Cell Sci. – 2009. – Vol. 122, No. 2. – P. 159–163.
4. Ingavle G.C., Leach J.K. Advancements in electrospinning of polymeric nanofibrous scaffolds for tissue engineering // Tissue Eng. Part B Rev. – 2014. – Vol. 20, No. 4. – P. 277– 293.
5. Антонова Л.В., Мухамадияров Р.А., Миронов А.В. и др. Оценка биосовместимости биодеградируемого сосудистого графта малого диаметра из полигидроксибутирата/ валерата и поликапролактона: морфологическое исследование // Гены & клетки. – 2015. – Т. 10, № 2. – С. 71–77.
6. AzimiNezhad M. Vascular endothelial growth factor from embryonic status to cardiovascular pathology // Rep. Biochem. Mol. Biol. – 2014. – Vol. 2, No. 2. – P. 59–69.
7. Thanigaimani S., Kichenadasse G., Mangoni A.A. The emerging role of vascular endothelial growth factor (VEGF) in vascular homeostasis: lessons from recent trials with anti-VEGF drugs// Curr. Vasc. Pharmacol. – 2011. – Vol. 9, No. 3. – P. 358–380.
8. Kalluri R. Basement membranes: structure: assembly and role in tumour angiogenesis // Nat. Rev. Cancer. – 2003. – No. 3. – P. 422–433.
9. Antonova L.V., Seifalian A.M., Kutikhin A.G. et al. Bioabsorbable bypass grafts biofunctionalised with RGD have enhanced biophysical properties and endothelialisation tested in vivo //Front. Pharmacol. – 2016. – Vol. 7. – P. 136.
10. Antonova L.V., Sevostyanova V.V., Kutikhin A.G. et al. Vascular endothelial growth factor improves physico-mechanical properties and enhances endothelialization of poly(3- hydroxybutyrate co-3-hydroxyvalerate)/poly(е-caprolactone) small-diameter vascular grafts in vivo // Front. Pharmacol. – 2016. – Vol. 7. – P. 230.
11. Rim N.G., Shin C.S., Shin H. Current approaches to electrospun nanofibers for tissue engineering // Biomed. Mater. – 2013. – Vol. 8, No. 1. – P. 014102.
12. Zhang X., Tsukada M., Morikawa H. et al. Production of silk sericin/silk fibroin blend nanofibers // Nanoscale Res. Lett. – 2011. – Vol. 6. – P. 510.
Review
For citations:
Krivkina E.O., Antonova L.V., Sevostyanova V.V., Velikanova E.A., Mironov A.V. BIOFUNCTIONALIZATION WITH RGD PEPTIDES AND VASCULAR ENDOTHELIAL GROWTH FACTOR ENHANCES ENDOTHELIALIZATION OF BIODEGRADABLE SMALL-DIAMETER VASCULAR GRAFTS. Siberian Journal of Clinical and Experimental Medicine. 2017;32(1):96-101. (In Russ.) https://doi.org/10.29001/2073-8552-2017-32-1-96-101